SHIMODA BIOTECH PTY LTD has a total of 36 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1994. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals, micro-structure and nano-technology and macromolecular chemistry and polymers are MERKUS FRANCISCUS W H M, COBIORES NV and JUROX PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | United States | 5 | |
#3 | Australia | 4 | |
#4 | Brazil | 3 | |
#5 | Canada | 3 | |
#6 | South Africa | 3 | |
#7 | Israel | 2 | |
#8 | Mexico | 2 | |
#9 | New Zealand | 2 | |
#10 | WIPO (World Intellectual Property Organization) | 2 | |
#11 | Chile | 1 | |
#12 | China | 1 | |
#13 | Hong Kong | 1 | |
#14 | Republic of Korea | 1 | |
#15 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Micro-structure and nano-technology | |
#3 | Macromolecular chemistry and polymers | |
#4 | Biotechnology | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Nanostructure applications | |
#4 | Polysaccharides | |
#5 | Peptides | |
#6 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Penkler Lawrence John | 17 |
#2 | Swart Henk | 10 |
#3 | Henk Swart | 2 |
#4 | Knoetze Steyn | 2 |
#5 | Cappelle Stefan | 1 |
#6 | Penkler Lawrence J | 1 |
#7 | Van Oudtshoorn Michael Coenraa | 1 |
#8 | Nicholson Douglas George M | 1 |
#9 | Tossut Pierre Patrick Aldo | 1 |
#10 | Griffith Vivienne Jean | 1 |
Publication | Filing date | Title |
---|---|---|
AU2011303475A1 | Fulvestrant compositions and methods of use | |
AU2011221386A1 | Stable injectable diclofenac compositions | |
WO2010070617A1 | Inclusion complexes of alpha-cyclodextrin and sildenafil salt | |
EP1574221A1 | Stable injectable diclofenac compositions | |
ZA200406021B | Pharmaceutical composition | |
US2009136527A1 | Retro-inverso gonadotropin-releasing hormone peptide and vaccine composition | |
NZ534598A | Pharmaceutical composition |